Mativ Holdings Q3 2026 sales fall 2.8%; net loss narrows
FAM sales grew 10.2% as SAS sales fell 10.9%, while consolidated adjusted EBITDA declined 7%.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Mativ Holdings, Inc. reported third-quarter 2026 sales of $499.5 million, down 2.8% year over year, and a GAAP net loss of $1.2 million, compared with a $3.2 million loss a year earlier. Adjusted EBITDA was $62.3 million, down 7%, while adjusted income was $17.5 million and adjusted EPS was $0.31. The July Wisconsin tornado weighed on results, particularly SAS; management said recovery remains on plan and expects inventory losses to be fully recoverable.
Results differed by segment: FAM sales rose 10.2% to $218.5 million, while SAS sales fell 10.9% to $281.0 million. For the first nine months, operating cash flow was $117.4 million, total debt was $976.4 million and net debt was $879.1 million as of September 30, 2026; nine-month net loss was $9.3 million versus $438.2 million, including prior-year goodwill impairment of $411.9 million. Mativ announced a $0.10-per-share quarterly dividend payable December 18, 2026, to holders of record November 27, 2026.
1 point · 0 major0 major · 1 point
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointNine-month net loss was $9.3 million versus $438.2 million, including prior-year goodwill impairment.
Negative
- Moderate pointThird-quarter adjusted EBITDA declined 7% to $62.3 million.
Filing Explained
At
8-K Event Classification
2 items: 2.02, 9.01
2 items
Item 2.02
Results of Operations and Financial Condition
Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Net sales: $499.5 million
GAAP net loss: $1.2 million loss
Adjusted EBITDA: $62.3 million
+5 more
8 metrics
Net sales
$499.5 million
Third quarter 2026; down 2.8% year over year.
GAAP net loss
$1.2 million loss
Third quarter 2026; compared with a $3.2 million loss in third quarter 2025.
Adjusted EBITDA
$62.3 million
Third quarter 2026; down 7% versus the prior-year period.
FAM net sales
$218.5 million
Third quarter 2026; up 10.2% on a reported basis year over year.
SAS net sales
$281.0 million
Third quarter 2026; down 10.9% year over year.
Net loss
$9.3 million loss
Nine months ended September 30, 2026; compared with a $438.2 million loss in 2025, which included $411.9 million of goodwill impairment.
Cash provided by operating activities
$117.4 million
Nine months ended September 30, 2026; up 3% versus the prior-year period.
Total debt
$976.4 million
As of September 30, 2026.
Key Terms
Adjusted EBITDA, organic basis, Free cash flow, net debt, +1 more
5 terms
Adjusted EBITDA financial
"Adjusted EBITDA was $62.3 million"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
organic basis financial
"2.3% on an organic basis"
"Organic basis" refers to the growth in a company's revenue or sales that comes from its existing operations, without including the effects of acquisitions, divestments, or other external changes. It shows how well a company's core business is performing on its own, much like tracking the natural growth of a plant without considering external factors. For investors, understanding organic growth helps assess the true strength and sustainability of a company's fundamental business.
Free cash flow financial
"Free cash flow was $90.5 million"
Free cash flow is the amount of money a company has left over after paying all its expenses and investing in its business, like buying equipment or updating facilities. It shows how much cash is available to reward shareholders, pay down debt, or save for future growth. This helps investors understand if a company is financially healthy and able to grow.
net debt financial
"The resulting net debt was $879.1 million"
Net debt is the total amount a company owes after subtracting the cash and assets it has that can be used to pay off that debt. It shows how much debt is truly a burden, helping investors understand if a company is financially healthy or heavily borrowed. Think of it like calculating how much money you owe after using your savings to pay part of it.
full valuation allowance financial
"certain jurisdictions that have a full valuation allowance"
Earnings Snapshot
Net sales: $499.5 million · Guidance included
Third quarter 2026
Net sales
$499.5 million
Down 2.8% year over year.
GAAP net loss
$1.2 million loss
Compared with a $3.2 million loss in third quarter 2025.
Adjusted EBITDA
$62.3 million
Down 7% versus the prior-year period.
Adjusted EPS
$0.31
Compared with $0.39 in third quarter 2025.
Guidance
Management said recovery from the July tornado remains on plan, expects inventory losses to be fully recoverable, and expressed confidence in delivering full-year financial performance ahead of the prior year.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were MATV's third-quarter 2026 sales and adjusted EBITDA?
Mativ reported sales of $499.5 million and adjusted EBITDA of $62.3 million for the third quarter of 2026. Sales declined 2.8% year over year, and adjusted EBITDA declined 7%. Adjusted income was $17.5 million and adjusted EPS was $0.31.
When is MATV's next dividend payable, and who qualifies?
Mativ announced a quarterly cash dividend of $0.10 per share, payable December 18, 2026, to stockholders of record as of November 27, 2026.
What affected MATV's third-quarter 2026 segment sales?
Mativ attributed the primary SAS sales decline to the July tornado incident's effects on Paper & Packaging. Lower volume/mix, including in Healthcare, and unfavorable currency also weighed on SAS sales; higher selling prices partly offset those factors.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Commission file number)
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (I.R.S. Employer Identification No.) | ||||||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||
1-770 -569-4229
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 2.02 Results of Operations and Financial Condition
On November 4, 2026, Mativ Holdings, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2026. The press release is attached hereto as Exhibit 99.1. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference to such filings.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| Exhibit No. | Description of Exhibit | ||||
| 99.1 | Press Release of Mativ Holdings, Inc. dated November 4, 2026 | ||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MATIV HOLDINGS, INC. | |||||
| (Registrant) | |||||
| By: | /s/ Shruti Singhal | ||||
| Shruti Singhal President and Chief Executive Officer | |||||
Dated: November 4, 2026
Exhibit 99.1
Mativ Announces Third Quarter 2026 Results
ALPHARETTA, GA, November 4, 2026 -– Mativ Holdings, Inc. ("Mativ" or the "Company") (NYSE: MATV) reported financial results for the three-months ended September 30, 2026.
Mativ Third Quarter 2026 Highlights1
•Sales of $499.5 million decreased 2.8% year over year, and 2.3% on an organic basis, primarily due to the impact of the previously disclosed tornado
•GAAP loss of $1.2 million versus GAAP loss of $3.2 million in prior year period; GAAP EPS was $(0.03)
•Adjusted income was $17.5 million; Adjusted EPS was $0.31
•Adjusted EBITDA was $62.3 million, down 7% versus prior year period
•Year-to-date profitability and cash flow performance pacing ahead of strong prior year
◦Gross profit was $295.9 million, up 7% versus prior year
◦Cash provided by operating activities was $117.4 million, up 3% versus prior year period
◦Free cash flow was $90.5 million, up 5% versus prior year period
Management Commentary
“Mativ’s third quarter performance demonstrated continued momentum across the business, highlighted by the FAM segment’s strongest sales growth ever, driven by robust demand in Aerospace & Defense and Transportation,” said Shruti Singhal, Mativ's President and CEO. “Our disciplined execution — which positioned Mativ to deliver year-over-year third-quarter Adjusted EBITDA growth prior to the operational disruption from the July tornado in Wisconsin — and our strong cash generation give us confidence in delivering full-year financial performance ahead of the prior year.
“Our response to the tornado is further proof of Mativ’s resilience and execution capabilities. Recovery remains on plan and we expect inventory losses to be fully recoverable. The team's efforts to quickly restore customer supply have earned strong praise from our customers. I want to thank our crisis management team and all employees for their exceptional customer commitment and dedication while navigating this challenge.
“With this solid operational foundation in place, we are pivoting to growth and executing on initiatives that will accelerate sustainable, profitable revenue growth, driving increased customer and shareholder value.”
1Non-GAAP (or "adjusted") measures are reconciled to GAAP measures at the end of this release. Refer to "Non-GAAP Financial Measures" for more information.
Mativ Third Quarter 2026 Financial Results
| Filtration & Advanced Materials (FAM) | Three Months Ended September 30, | ||||||||||||||||||||||||||||
| (in millions; unaudited) | 2026 | 2025 | Change | 2026 | 2025 | ||||||||||||||||||||||||
| Net Sales | $ | 218.5 | $ | 198.3 | $ | 20.2 | |||||||||||||||||||||||
GAAP Gross Profit & Margin % | $ | 51.5 | $ | 42.5 | $ | 9.0 | 23.6 | % | 21.4 | % | |||||||||||||||||||
| Adjusted EBITDA & Margin % | $ | 39.6 | $ | 32.9 | $ | 6.7 | 18.1 | % | 16.6 | % | |||||||||||||||||||
Filtration & Advanced Materials (FAM) segment sales, comprised primarily of filtration media and components, advanced films, coating and converting solutions, and extruded mesh products, were $218.5 million, up 11.6% on an organic basis, and 10.2% on a reported basis versus the prior year period, reflecting higher volume/mix, including the impact from an exited facility, and higher selling prices.
Adjusted EBITDA (see non-GAAP reconciliations) of $39.6 million increased 20.4% while Adjusted EBITDA margin of 18.1% increased 150 basis points versus prior year. Higher volume/mix and favorable price vs. cost performance were partially offset by higher manufacturing costs.
| Sustainable & Adhesive Solutions (SAS) | Three Months Ended September 30, | ||||||||||||||||||||||||||||
| (in millions; unaudited) | 2026 | 2025 | Change | 2026 | 2025 | ||||||||||||||||||||||||
| Net Sales | $ | 281.0 | $ | 315.4 | $ | (34.4) | |||||||||||||||||||||||
| GAAP Gross Profit & Margin % | $ | 46.2 | $ | 56.9 | $ | (10.7) | 16.4 | % | 18.0 | % | |||||||||||||||||||
| Adjusted EBITDA & Margin % | $ | 32.6 | $ | 43.3 | $ | (10.7) | 11.6 | % | 13.7 | % | |||||||||||||||||||
Sustainable & Adhesive Solutions (SAS) segment sales, comprised primarily of tapes, labels, liners, specialty paper, packaging and healthcare solutions, of $281.0 million were down 10.9% versus the prior year period primarily due to the effects of the July tornado incident on our Paper & Packaging business. Lower volume/mix including in Healthcare, and unfavorable currency were partially offset by higher selling prices.
Adjusted EBITDA (see non-GAAP reconciliations) of $32.6 million decreased 24.7% while Adjusted EBITDA margin of 11.6% decreased 210 basis points compared to the prior year period. Lower volume/mix and higher distribution expenses were partially offset by favorable price vs. cost performance.
| Unallocated | Three Months Ended September 30, | ||||||||||||||||||||||||||||
| (in millions; unaudited) | 2026 | 2025 | Change | 2026 | 2025 | ||||||||||||||||||||||||
| GAAP Operating Expense & % of Sales | $ | (14.2) | $ | (14.8) | $ | 0.6 | (2.8) | % | (2.9) | % | |||||||||||||||||||
Adjusted EBITDA & % of Sales | $ | (9.9) | $ | (9.4) | $ | (0.5) | (2.0) | % | (1.8) | % | |||||||||||||||||||
GAAP operating expenses decreased $0.6 million year-over-year, and adjusted unallocated expenses (EBITDA) (see non-GAAP reconciliations) increased $0.5 million versus prior year.
Interest expense was $18.1 million versus $17.7 million in the prior year period, mainly due to higher average rates on the floating portion of our outstanding debt in 2026.
Other expense, net was $0.4 million and compared to other expense of $3.9 million in the prior year period. The improvement was primarily attributed to pension costs and foreign currency losses in 2025.
Tax expense was $2.6 million and tax rate was 185.7% for the three months ended September 30, 2026, primarily driven by our geographical earnings mix and our inability to benefit from losses in certain jurisdictions that have a full valuation allowance.
Non-GAAP Adjustments reflect items included in GAAP gross profit, income, and EPS, but excluded from adjusted results (see non-GAAP reconciliation tables for additional details). The most significant adjustments to the third quarter 2026 results were:
•$0.26 per share of purchase accounting expenses (purchase accounting expenses reflect primarily ongoing non-cash intangible asset amortizations associated with mergers and acquisitions)
•$0.08 per share of restructuring, restructuring related, and impairment expenses
Cash Flow & Debt
Year-to-date 2026 cash provided by operating activities was $117.4 million. Capital spending totaled $26.9 million. Working capital was a $11.9 million source of cash due to the impact of an increase in accounts payable and other current liabilities and accrued income taxes, partially offset by an increase in accounts receivable and inventories.
Total debt was $976.4 million as of September 30, 2026, an improvement of $52.5 million year-over-year. Cash and cash equivalents was $97.3 million. The resulting net debt was $879.1 million. Total liquidity was approximately $373.5 million, consisting of $97.3 million of Cash and cash equivalents and $276.2 million of revolver availability. The Company's debt is expected to mature on a staggered basis through 2033.
Dividends
On November 4, 2026, the Company announced its next quarterly cash dividend of $0.10 per share payable on December 18, 2026 to stockholders of record as of November 27, 2026.
Conference Call
Mativ will hold a conference call to review third quarter 2026 results with investors and analysts at 8:30 a.m. Eastern time on Thursday, November 5, 2026. The earnings conference call will be simultaneously broadcast over the Internet at http://ir.mativ.com. To listen to the call, please go to the Company’s website at least 15 minutes prior to the call to register and to download and install any necessary audio software. For those unable to listen to the live broadcast, a replay will be available on the Company’s website shortly after the call.
About Mativ
Mativ Holdings, Inc. is a global leader in specialty materials, solving our customers’ most complex challenges by engineering bold, innovative solutions that connect, protect and purify our world. Headquartered in Alpharetta, Georgia, we manufacture on three continents and generate sales in over 100 countries through our family of business-to-business and consumer product brands. The company’s two operating segments, Filtration & Advanced Materials and Sustainable & Adhesive Solutions, target premium applications across diversified and growing categories. Our broad portfolio of technologies combines polymers, fibers and resins to optimize the performance of our customers’ products across multiple stages of the value chain. Our leading positions are a testament to our best-in-class global manufacturing, supply chain and materials science capabilities. We drive innovation and enhance performance, finding potential in the impossible.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") that are subject to the safe harbor created by the Act and other legal protections. Forward-looking statements include, without limitation, those regarding the Company’s business plans, strategies and outlook, the adequacy of our sources of liquidity and capital, our expectations regarding dividends and share repurchases, the amount of capital spending and/or common stock repurchases, future cash flows, purchase accounting impacts, and other statements generally identified by words such as "believe," "expect," "intend," "guidance," "plan," "forecast," "potential," "anticipate," "confident," "project," "appear," "future," "should," "likely," "could," "may," "will," "typically" and similar words.
These forward-looking statements are prospective in nature and not based on historical facts, but rather on current expectations and on numerous assumptions regarding the business strategies and the environment in which the Company’s business shall operate in the future and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by those statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that may cause actual results to differ
materially from our expectations as of the date of this release. These risks include, among other things, the following factors:
•Risks associated with the implementation of our strategic growth initiatives, including diversification, and the Company's understanding of, and entry into, new industries and technologies;
•Risks associated with acquisitions, dispositions, strategic transactions and global asset realignment initiatives of Mativ;
•Risks related to the impairment of goodwill;
•Adverse changes in our end-market sectors impacting key customers;
•Changes in the source and intensity of competition in our commercial end-markets;
•Adverse changes in sales or production volumes, pricing and/or manufacturing costs;
•Seasonal or cyclical market and industry fluctuations which may result in reduced net sales and operating profits during certain periods;
•Risks associated with our technological advantages in our intellectual property and the likelihood that our current technological advantages are unable to continue indefinitely;
•Supply chain disruptions, including the failure of one or more material suppliers, including energy, resin, fiber, and chemical suppliers, to supply materials as needed to maintain our product plans and cost structure;
•Increases in operating costs due to inflation and continuing increases in the inflation rate or otherwise, such as labor expense, compensation and benefits costs;
•Our ability to attract and retain key personnel, labor shortages, labor strikes, stoppages or other disruptions;
•Changes in general economic, financial and credit conditions in the U.S., Europe, China and elsewhere, including the impact thereof on currency exchange rates (including any weakening of the Euro) and on interest rates;
•A failure in our risk management and/or currency or interest rate swaps and hedging programs, including the failures of any insurance company or counterparty;
•Changes in the manner in which we finance our debt and future capital needs, including potential acquisitions;
•Changes in tax rates, the adoption of new U.S. or international tax legislation or exposure to additional tax liabilities;
•Uncertainty as to the long-term value of the common stock of Mativ;
•Changes in employment, wage and hour laws and regulations in the U.S. and elsewhere, including unionization rules and regulations by the National Labor Relations Board, equal pay initiatives, additional anti-discrimination rules or tests and different interpretations of exemptions from overtime laws;
•The impact of tariffs, the imposition of any future additional tariffs and other trade barriers, the effects of retaliatory trade measures, and the impact of tariff uncertainty on macroeconomic conditions;
•Existing and future governmental regulation and the enforcement thereof that may materially restrict or adversely affect how we conduct business and our financial results;
•Weather conditions, including potential impacts, if any, from climate change, known and unknown, and natural disasters or unusual weather events;
•Risks associated with international conflicts and disputes, such as the ongoing conflict between Russia and Ukraine, and conflicts in the Middle East, and their corresponding impact on global macroeconomic conditions (including volatility in oil prices), as well as adverse impacts on our ability to supply products into affected regions, due to the corresponding effects on demand, the application of international sanctions, or practical consequences on transportation, banking transactions, and other commercial activities in troubled regions;
•Compliance with the FCPA and other anti-corruption laws or trade control laws, as well as other laws governing our operations;
•Risks associated with pandemics and other public health emergencies;
•The number, type, outcomes (by judgment or settlement) and costs of legal, tax, regulatory or administrative proceedings, litigation and/or amnesty programs;
•Increased scrutiny from stakeholders related to environmental, social and governance ("ESG") matters, as well as our ability to achieve our broader ESG goals and objectives;
•Costs and timing of implementation of any upgrades or changes to our information technology systems;
•Failure by us to comply with any privacy or data security laws or to protect against theft of customer, employee and corporate sensitive information;
•Information technology system failures, data security breaches, network disruptions, and cybersecurity events; and
•Other factors described elsewhere in this document and from time to time in documents that we file with the SEC.
All forward-looking statements made in this document are qualified by these cautionary statements. Forward-looking statements herein are made only as of the date of this document, and Mativ undertakes no obligation, other than as may be required by law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, or changes in future operating results over time or otherwise. For a more detailed discussion of these factors, also see the information under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Mativ's most recent annual report on Form 10-K for the year ended December 31, 2025 and any material updates to these factors contained in any of Mativ’s future filings with the SEC. The discussion of these risks is specifically incorporated by reference into this release. The financial results reported in this release are unaudited.
Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance unless expressed as such and should only be viewed as historical data. The financial results reported in this release are unaudited.
Non-GAAP Financial Measures
Certain financial measures and comments contained in this press release exclude restructuring and impairment expenses, certain purchase accounting adjustments related to prior acquisitions, organizational realignment costs, divestiture costs, interest expense, stock-based compensation expense, the effect of income tax provisions and other tax impacts, capital spending, capitalized software costs, cloud-based software costs and depreciation and amortization. This press release also provides certain information regarding the Company's financial results excluding currency impacts. This information estimates the impact of changes in foreign currency rates on the translation of the Company's current financial results as compared to the applicable comparable period and is derived by translating the current local currency results into U.S. Dollars based upon the foreign currency exchange rates for the applicable comparable period. Financial measures which exclude or include these items have not been determined in accordance with accounting principles generally accepted in the United States (GAAP) and are therefore "non-GAAP" financial measures. Reconciliations of these non-GAAP financial measures to the most closely analogous measure determined in accordance with GAAP are included in the financial schedules attached to this release.
The Company believes that the presentation of non-GAAP financial measures in addition to the related GAAP measures provides investors with greater transparency on the information used by the Company’s management in its financial and operational decision-making. Management also believes that the non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company’s financial and operational performance in the same way that management evaluates the Company's financial performance. Management believes that providing this information enables investors to better understand the Company’s operating performance and financial condition. These non-GAAP financial measures are not calculated or presented in accordance with, and are not intended to be considered in isolation or as alternatives or substitutes for, or superior to, financial measures prepared and presented in accordance with GAAP, and should be read only in conjunction with the Company's financial measures prepared and presented in accordance with GAAP. The non-GAAP financial measures used in this release may be different from the measures used by other companies.
SOURCE: Mativ Holdings, Inc.
CONTACT
Chris Kuepper, IRC
Director, Investor Relations
+1-770-569-4229
Website: http://www.mativ.com
MATIV HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME (LOSS)
(in millions, except per share amounts)
(Unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||||||||
| 2026 | 2025 | % Change | 2026 | 2025 | % Change | ||||||||||||||||||||||||||||||
| Net sales | $ | 499.5 | $ | 513.7 | (2.8)% | $ | 1,510.9 | $ | 1,523.9 | (0.9)% | |||||||||||||||||||||||||
| Cost of products sold | 401.8 | 414.3 | (3.0)% | 1,215.0 | 1,248.2 | (2.7)% | |||||||||||||||||||||||||||||
Gross profit | 97.7 | 99.4 | (1.7)% | 295.9 | 275.7 | 7.3% | |||||||||||||||||||||||||||||
| Selling and general expense | 54.8 | 53.7 | 2.0% | 166.2 | 174.2 | (4.6)% | |||||||||||||||||||||||||||||
| Research and development expense | 4.8 | 5.6 | (14.3)% | 15.2 | 18.6 | (18.3)% | |||||||||||||||||||||||||||||
| Intangible asset amortization expense | 15.5 | 16.0 | (3.1)% | 47.3 | 47.3 | —% | |||||||||||||||||||||||||||||
| Total nonmanufacturing expenses | 75.1 | 75.3 | (0.3)% | 228.7 | 240.1 | (4.7)% | |||||||||||||||||||||||||||||
| Goodwill impairment expense | — | — | N.M. | — | 411.9 | N.M. | |||||||||||||||||||||||||||||
| Restructuring and other impairment expense | 2.7 | 8.1 | (66.7)% | 4.7 | 18.2 | (74.2)% | |||||||||||||||||||||||||||||
Operating profit (loss) | 19.9 | 16.0 | 24.4% | 62.5 | (394.5) | N.M. | |||||||||||||||||||||||||||||
| Interest expense | 18.1 | 17.7 | 2.3% | 54.9 | 54.1 | 1.5% | |||||||||||||||||||||||||||||
| Loss on debt extinguishment | — | — | N.M. | 8.7 | — | N.M. | |||||||||||||||||||||||||||||
| Other income (expense), net | (0.4) | (3.9) | (89.7)% | 0.6 | (4.2) | N.M. | |||||||||||||||||||||||||||||
Income (loss) before income taxes | 1.4 | (5.6) | N.M. | (0.5) | (452.8) | (99.9)% | |||||||||||||||||||||||||||||
Income tax expense (benefit), net | 2.6 | (2.4) | N.M. | 8.8 | (14.6) | N.M. | |||||||||||||||||||||||||||||
Net loss | $ | (1.2) | $ | (3.2) | (62.5)% | $ | (9.3) | $ | (438.2) | (97.9)% | |||||||||||||||||||||||||
Net loss per share: | |||||||||||||||||||||||||||||||||||
| Basic | $ | (0.03) | $ | (0.06) | (50.0)% | $ | (0.18) | $ | (8.04) | (97.8)% | |||||||||||||||||||||||||
| Diluted | $ | (0.03) | $ | (0.06) | (50.0)% | $ | (0.18) | $ | (8.04) | (97.8)% | |||||||||||||||||||||||||
| Weighted average shares outstanding: | |||||||||||||||||||||||||||||||||||
| Basic | 55,190,100 | 54,671,900 | 55,046,800 | 54,582,100 | |||||||||||||||||||||||||||||||
| Diluted | 55,190,100 | 54,671,900 | 55,046,800 | 54,582,100 | |||||||||||||||||||||||||||||||
N.M. - Not Meaningful
MATIV HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in millions)
(Unaudited)
| September 30, 2026 | December 31, 2025 | ||||||||||
| ASSETS | |||||||||||
| Cash and cash equivalents | $ | 97.3 | $ | 84.2 | |||||||
| Restricted cash | 4.2 | 5.6 | |||||||||
| Accounts receivable, net | 250.3 | 180.9 | |||||||||
| Inventories, net | 329.1 | 329.1 | |||||||||
| Income taxes receivable | 9.0 | 17.7 | |||||||||
| Other current assets | 19.4 | 21.1 | |||||||||
| Total current assets | 709.3 | 638.6 | |||||||||
| Property, plant and equipment, net | 585.2 | 624.9 | |||||||||
| Operating lease right-of-use assets | 57.3 | 48.4 | |||||||||
| Deferred income tax assets | 97.3 | 104.0 | |||||||||
| Goodwill | 56.2 | 57.6 | |||||||||
| Intangible assets, net | 459.6 | 514.2 | |||||||||
| Other assets | 65.6 | 63.9 | |||||||||
| Total assets | $ | 2,030.5 | $ | 2,051.6 | |||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||
| Current debt | $ | 3.8 | $ | 2.9 | |||||||
| Operating lease liabilities | 8.8 | 9.0 | |||||||||
| Accounts payable | 219.6 | 160.7 | |||||||||
| Income taxes payable | 3.4 | 1.5 | |||||||||
| Accrued expenses and other current liabilities | 131.8 | 111.2 | |||||||||
| Total current liabilities | 367.4 | 285.3 | |||||||||
| Long-term debt | 972.6 | 1,015.3 | |||||||||
| Finance lease liabilities, noncurrent | 14.7 | 16.1 | |||||||||
| Operating lease liabilities, noncurrent | 47.4 | 38.8 | |||||||||
| Pension and other postretirement benefits | 49.1 | 53.8 | |||||||||
| Deferred income tax liabilities | 69.3 | 74.9 | |||||||||
| Other liabilities | 42.9 | 68.7 | |||||||||
| Total liabilities | 1,563.4 | 1,552.9 | |||||||||
| Stockholders' equity: | |||||||||||
Preferred stock, $0.10 par value; 10,000,000 shares authorized; none issued or outstanding | — | — | |||||||||
Common stock, $0.10 par value; 100,000,000 shares authorized; 55,191,997 and 54,681,114 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively | 5.5 | 5.5 | |||||||||
| Additional paid-in-capital | 688.7 | 685.0 | |||||||||
Accumulated deficit | (222.0) | (195.8) | |||||||||
Accumulated other comprehensive income (loss), net of tax | (5.1) | 4.0 | |||||||||
| Total stockholders' equity | 467.1 | 498.7 | |||||||||
| Total liabilities and stockholders' equity | $ | 2,030.5 | $ | 2,051.6 | |||||||
MATIV HOLDINGS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(in millions)
(Unaudited)
| Nine Months Ended September 30, | |||||||||||
| 2026 | 2025 | ||||||||||
| Operating | |||||||||||
Net loss | $ | (9.3) | $ | (438.2) | |||||||
Adjustments to reconcile Net loss to Net cash provided by operations: | |||||||||||
| Depreciation and amortization | 102.7 | 106.3 | |||||||||
| Amortization of deferred issuance costs | 4.7 | 6.2 | |||||||||
| Goodwill and other impairments | 1.4 | 423.2 | |||||||||
| Deferred income tax | 0.1 | (19.5) | |||||||||
| Pension and other postretirement benefits | (3.5) | (2.9) | |||||||||
| Stock-based compensation | 5.7 | 8.6 | |||||||||
(Gain) loss on disposal of assets | 0.5 | (0.8) | |||||||||
(Gain) loss on foreign currency transactions | (2.1) | 5.8 | |||||||||
| Loss on debt extinguishment | 8.7 | — | |||||||||
| Other items, net | (3.4) | (9.5) | |||||||||
| Net changes in operating working capital | 11.9 | 35.3 | |||||||||
Net cash provided by operations | 117.4 | 114.5 | |||||||||
| Investing | |||||||||||
| Capital spending | (26.9) | (28.7) | |||||||||
| Proceeds from disposal of assets | — | 2.9 | |||||||||
Cash received from settlement of cross-currency swap contracts | — | 3.4 | |||||||||
| Other investing | (0.1) | (0.6) | |||||||||
Net cash used in investing | (27.0) | (23.0) | |||||||||
| Financing | |||||||||||
| Cash dividends paid | (17.0) | (16.8) | |||||||||
| Proceeds from long-term debt | 705.7 | 64.0 | |||||||||
| Payments on long-term debt | (728.1) | (131.1) | |||||||||
| Payments for debt issuance costs | (32.7) | — | |||||||||
| Payments on financing lease obligations | (2.5) | (2.5) | |||||||||
| Shares withheld for employee taxes | (2.2) | (1.4) | |||||||||
Net cash used in financing | (76.8) | (87.8) | |||||||||
| Effect of exchange rate changes on Cash and cash equivalents and Restricted cash | (1.9) | 4.9 | |||||||||
Increase in cash and cash equivalents and Restricted cash | 11.7 | 8.6 | |||||||||
| Cash and cash equivalents and Restricted cash at beginning of period | 89.8 | 94.3 | |||||||||
| Cash and cash equivalents and Restricted cash at end of period | $ | 101.5 | $ | 102.9 | |||||||
MATIV HOLDINGS, INC. AND SUBSIDIARIES
BUSINESS SEGMENT REPORTING
(in millions)
(Unaudited)
| Segment Results | Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||
| 2026 | 2025 | % Change | 2026 | 2025 | % Change | ||||||||||||||||||||||||||||||
| Net sales | |||||||||||||||||||||||||||||||||||
| FAM | $ | 218.5 | $ | 198.3 | 10.2 | % | $ | 608.5 | $ | 590.3 | 3.1 | % | |||||||||||||||||||||||
| SAS | 281.0 | 315.4 | (10.9) | % | 902.4 | 933.6 | (3.3) | % | |||||||||||||||||||||||||||
| Total Consolidated | $ | 499.5 | $ | 513.7 | (2.8) | % | $ | 1,510.9 | $ | 1,523.9 | (0.9) | % | |||||||||||||||||||||||
| Cost of products sold | |||||||||||||||||||||||||||||||||||
| FAM | $ | 167.0 | $ | 155.8 | 7.2 | % | $ | 469.7 | $ | 466.8 | 0.6 | % | |||||||||||||||||||||||
| SAS | 234.8 | 258.5 | (9.2) | % | 745.3 | 781.4 | (4.6) | % | |||||||||||||||||||||||||||
| Consolidated | $ | 401.8 | $ | 414.3 | (3.0) | % | $ | 1,215.0 | $ | 1,248.2 | (2.7) | % | |||||||||||||||||||||||
| Gross profit | |||||||||||||||||||||||||||||||||||
| FAM | $ | 51.5 | $ | 42.5 | 21.2 | % | $ | 138.8 | $ | 123.5 | 12.4 | % | |||||||||||||||||||||||
| SAS | 46.2 | 56.9 | (18.8) | % | 157.1 | 152.2 | 3.2 | % | |||||||||||||||||||||||||||
| Consolidated | $ | 97.7 | $ | 99.4 | (1.7) | % | $ | 295.9 | $ | 275.7 | 7.3 | % | |||||||||||||||||||||||
| Adjustments to Gross profit and Unallocated nonmanufacturing expenses | Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
FAM - Selling and general expense and Research and development expense(1)(2) | $ | (19.4) | $ | (19.0) | $ | (57.0) | $ | (59.4) | |||||||||||||||
| FAM - Restructuring related costs | $ | 1.5 | $ | 2.5 | $ | 1.5 | $ | 2.5 | |||||||||||||||
| FAM - Depreciation classified as Cost of products sold | $ | 6.0 | $ | 6.7 | $ | 18.6 | $ | 20.0 | |||||||||||||||
FAM - Stock-based compensation(3) | $ | — | $ | 0.2 | $ | 0.5 | $ | 0.6 | |||||||||||||||
SAS - Selling and general expense and Research and development expense(1)(2) | $ | (25.4) | $ | (25.2) | $ | (78.4) | $ | (77.4) | |||||||||||||||
| SAS - Tornado related costs, net of insurance recoveries | $ | 0.8 | $ | — | $ | 0.8 | $ | — | |||||||||||||||
| SAS - Depreciation classified as Cost of products sold | $ | 10.7 | $ | 11.3 | $ | 33.7 | $ | 36.4 | |||||||||||||||
SAS - Stock-based compensation(3) | $ | 0.3 | $ | 0.3 | $ | 0.6 | $ | 1.1 | |||||||||||||||
Unallocated - Selling and general expense and Research and development expense(2) | $ | (13.8) | $ | (14.4) | $ | (42.9) | $ | (53.4) | |||||||||||||||
Unallocated - Stock-based compensation(3) | $ | 1.8 | $ | 2.0 | $ | 5.0 | $ | 5.4 | |||||||||||||||
| Unallocated - Organizational realignment costs | $ | — | $ | 0.3 | $ | — | $ | 11.4 | |||||||||||||||
| Unallocated - Divestiture costs | $ | — | $ | 0.3 | $ | — | $ | 1.4 | |||||||||||||||
Unallocated - Financing fees(4) | $ | 1.7 | $ | 2.0 | $ | 5.1 | $ | 5.9 | |||||||||||||||
| Unallocated - Amortization of cloud-based software costs | $ | 0.4 | $ | 0.4 | $ | 1.4 | $ | 1.0 | |||||||||||||||
(1) Selling and general expense and Research and development expense are included in the reconciliation from Segment Gross profit to Adjusted EBITDA. | |||||||||||||||||||||||
(2) Selling and general expense and Research and development expense excludes depreciation expense classified as Selling and general expense. | |||||||||||||||||||||||
(3) Stock-based compensation excludes stock-based compensation included in restructuring and organizational realignment costs. | |||||||||||||||||||||||
(4) Financing fees incurred for the Receivables Sales Agreement. | |||||||||||||||||||||||
| Adjusted EBITDA | Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||||||||||
| Return on Net Sales | Return on Net Sales | ||||||||||||||||||||||||||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||||||||||||||||||||||
| FAM | $ | 39.6 | $ | 32.9 | 18.1 | % | 16.6 | % | $ | 102.4 | $ | 87.2 | 16.8 | % | 14.8 | % | |||||||||||||||||||||||||||||||
| SAS | 32.6 | 43.3 | 11.6 | % | 13.7 | % | 113.8 | 112.3 | 12.6 | % | 12.0 | % | |||||||||||||||||||||||||||||||||||
| Unallocated | (9.9) | (9.4) | (2.0) | % | (1.8) | % | (31.4) | (28.3) | (2.1) | % | (1.9) | % | |||||||||||||||||||||||||||||||||||
| Total Consolidated | $ | 62.3 | $ | 66.8 | 12.5 | % | 13.0 | % | $ | 184.8 | $ | 171.2 | 12.2 | % | 11.2 | % | |||||||||||||||||||||||||||||||
| MATIV HOLDINGS, INC. AND SUBSIDIARIES | |||||||||||||||||
| BUSINESS SEGMENT REPORTING | |||||||||||||||||
| (in millions) | |||||||||||||||||
| (Unaudited) | |||||||||||||||||
| Non-GAAP Reconciliation of Organic Net Sales Growth | FAM | SAS | Consolidated Mativ | ||||||||||||||
| Three Months Ended September 30, | |||||||||||||||||
| Mativ 2025 Net Sales | $ | 198.3 | $ | 315.4 | $ | 513.7 | |||||||||||
| Divestiture/closure adjustments | (2.5) | — | (2.5) | ||||||||||||||
| Mativ 2025 comparable Net Sales | $ | 195.8 | $ | 315.4 | $ | 511.2 | |||||||||||
Mativ 2026 Net Sales | $ | 218.5 | $ | 281.0 | $ | 499.5 | |||||||||||
| Divestiture/closure adjustments | — | — | — | ||||||||||||||
Mativ 2026 comparable Net Sales | $ | 218.5 | $ | 281.0 | $ | 499.5 | |||||||||||
| Organic growth | 11.6 | % | (10.9) | % | (2.3) | % | |||||||||||
Currency effects on 2026 | $ | (0.7) | $ | (2.0) | $ | (2.7) | |||||||||||
Mativ 2026 comparable Net Sales with Currency Adjustment | $ | 219.2 | $ | 283.0 | $ | 502.2 | |||||||||||
| Organic constant currency growth | 12.0 | % | (10.3) | % | (1.8) | % | |||||||||||
| RECONCILIATION OF NON-GAAP FINANCIAL MEASURES AND SUPPLEMENTAL DATA | |||||||||||||||||||||||
| (in millions, except per share amounts) | |||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
Net income (loss) | $ | (1.2) | $ | (3.2) | $ | (9.3) | $ | (438.2) | |||||||||||||||
| Plus: Restructuring, restructuring related, and impairment expenses | 4.2 | 9.7 | 6.2 | 19.4 | |||||||||||||||||||
| Plus: Tornado related costs, net of insurance recoveries | 0.8 | — | 0.8 | — | |||||||||||||||||||
| Plus: Goodwill impairment | — | — | — | 347.2 | |||||||||||||||||||
| Plus: Purchase accounting adjustments | 14.0 | 14.7 | 42.5 | 43.7 | |||||||||||||||||||
| Plus: Litigation/tax settlement | — | — | 1.0 | — | |||||||||||||||||||
| Plus: Organizational realignment costs | — | 0.3 | — | 11.4 | |||||||||||||||||||
| Plus: Divestiture costs | — | 0.3 | — | 1.4 | |||||||||||||||||||
| Plus: Loss on debt extinguishment | — | — | 8.7 | — | |||||||||||||||||||
| Plus: Change of valuation allowance on tax attributes | — | (0.2) | — | 49.4 | |||||||||||||||||||
| Plus: Tax legislative changes, net of other discrete items | (0.3) | — | (0.3) | (0.2) | |||||||||||||||||||
| Adjusted income (loss) | $ | 17.5 | $ | 21.6 | $ | 49.6 | $ | 34.1 | |||||||||||||||
| Earnings (loss) per share - diluted | $ | (0.03) | $ | (0.06) | $ | (0.18) | $ | (8.04) | |||||||||||||||
| Plus: Restructuring, restructuring related, and impairment expenses | 0.08 | 0.18 | 0.11 | 0.35 | |||||||||||||||||||
| Plus: Tornado related costs, net of insurance recoveries | 0.01 | — | 0.01 | — | |||||||||||||||||||
| Plus: Goodwill impairment | — | — | — | 6.32 | |||||||||||||||||||
| Plus: Purchase accounting adjustments | 0.26 | 0.27 | 0.76 | 0.80 | |||||||||||||||||||
| Plus: Litigation/tax settlement | — | — | 0.02 | — | |||||||||||||||||||
| Plus: Organizational realignment costs | — | — | — | 0.20 | |||||||||||||||||||
| Plus: Divestiture costs | — | — | — | 0.02 | |||||||||||||||||||
| Plus: Loss on debt extinguishment | — | — | 0.16 | — | |||||||||||||||||||
| Plus: Change of valuation allowance on tax attributes | — | — | — | 0.91 | |||||||||||||||||||
| Plus: Tax legislative changes, net of other discrete items | (0.01) | — | (0.01) | — | |||||||||||||||||||
| Adjusted Earnings (loss) per share - diluted | $ | 0.31 | $ | 0.39 | $ | 0.87 | $ | 0.56 | |||||||||||||||
| MATIV HOLDINGS, INC. AND SUBSIDIARIES | |||||||||||||||||||||||
| RECONCILIATION OF NON-GAAP FINANCIAL MEASURES AND SUPPLEMENTAL DATA | |||||||||||||||||||||||
| (in millions, except per share amounts) | |||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
Net income (loss) | $ | (1.2) | $ | (3.2) | $ | (9.3) | $ | (438.2) | |||||||||||||||
| Plus: Interest expense | 18.1 | 17.7 | 54.9 | 54.1 | |||||||||||||||||||
| Plus: Financing fees | 1.7 | 2.0 | 5.1 | 5.9 | |||||||||||||||||||
| Plus: Provision for income taxes | 2.6 | (2.4) | 8.8 | (14.6) | |||||||||||||||||||
| Plus: Depreciation & amortization | 33.2 | 34.7 | 102.7 | 106.3 | |||||||||||||||||||
| Plus: Amortization of cloud-based software costs | 0.4 | 0.4 | 1.4 | 1.0 | |||||||||||||||||||
| Plus: Stock-based compensation | 2.1 | 2.5 | 6.1 | 7.1 | |||||||||||||||||||
| Plus: Restructuring, restructuring related, and impairment expenses | 4.2 | 10.6 | 6.2 | 20.7 | |||||||||||||||||||
| Plus: Tornado related costs, net of insurance recoveries | 0.8 | — | 0.8 | — | |||||||||||||||||||
| Plus: Goodwill Impairments | — | — | — | 411.9 | |||||||||||||||||||
| Plus: Organizational realignment costs | — | 0.3 | — | 11.4 | |||||||||||||||||||
| Plus: Divestiture costs | — | 0.3 | — | 1.4 | |||||||||||||||||||
| Plus: Loss on debt extinguishment | — | — | 8.7 | — | |||||||||||||||||||
| Plus: Other (income) expense, net | 0.4 | 3.9 | (0.6) | 4.2 | |||||||||||||||||||
| Adjusted EBITDA | $ | 62.3 | $ | 66.8 | $ | 184.8 | $ | 171.2 | |||||||||||||||
Cash provided by operating activities | $ | 48.5 | $ | 72.8 | $ | 117.4 | $ | 114.5 | |||||||||||||||
| Less: Capital spending | (11.0) | (6.1) | (26.9) | (28.7) | |||||||||||||||||||
| Free cash flow | $ | 37.5 | $ | 66.7 | $ | 90.5 | $ | 85.8 | |||||||||||||||
| September 30, 2026 | December 31, 2025 | ||||||||||||||||||||||
| Total debt | $ | 976.4 | $ | 1,018.2 | |||||||||||||||||||
| Less: Cash | 97.3 | 84.2 | |||||||||||||||||||||
| Net debt | $ | 879.1 | $ | 934.0 | |||||||||||||||||||